What is the initial infusion rate of Nitroglycerin (NTG) in drops per minute?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitroglycerin Infusion Rate in Drops Per Minute

When using non-absorbing tubing with a standard micro-drip set (60 microdrops/mL), start intravenous nitroglycerin at 5-10 mcg/min, which equals 3-6 drops per minute when using a 100 mcg/mL concentration. 1

Initial Setup and Concentration

  • Dilute 50 mg nitroglycerin in 500 mL of D5W or normal saline to achieve a standard concentration of 100 mcg/mL 1
  • Use an infusion set with a drip chamber that delivers approximately 60 microdrops/mL 1
  • Critical: Use non-absorbing tubing, as PVC tubing absorbs significant amounts of nitroglycerin and requires higher doses 2, 1

Starting Dose Calculation

For a 100 mcg/mL concentration with 60 microdrops/mL:

  • 5 mcg/min = 3 drops/min (0.05 mL/min × 60 drops/mL)
  • 10 mcg/min = 6 drops/min (0.10 mL/min × 60 drops/mL)

The ACC/AHA guidelines recommend starting at 10 mcg/min when using non-absorbing tubing 2, while the FDA label specifies 5 mcg/min as the initial dose with non-absorbing sets and infusion pumps 1

Titration Protocol

  • Increase by 5-10 mcg/min (3-6 drops/min) every 3-5 minutes until symptom relief or blood pressure response occurs 2, 3, 1
  • If no response at 20 mcg/min (12 drops/min), use larger increments of 10 mcg/min (6 drops/min), then 20 mcg/min (12 drops/min) 2, 3
  • Once partial response is achieved, reduce increment size and lengthen intervals between increases 2, 1
  • Stop titrating if symptoms resolve—no need to continue increasing for blood pressure effect alone 2, 3

Critical Safety Warnings

Gravity-driven micro-drip infusion is inherently unreliable for precise drug delivery:

  • When the roller clamp is fully open ("wide-open" flow), drug delivery becomes unpredictable and can vary up to 3-fold depending on catheter size, IV height, and carrier flow rates 4
  • An infusion pump is strongly preferred over gravity drip for nitroglycerin to ensure exact and constant delivery 1, 4

Absolute contraindications:

  • Systolic BP <90 mmHg or >30 mmHg below baseline 2, 3, 5
  • Sildenafil use within 24 hours or tadalafil within 48 hours (risk of fatal hypotension) 2, 3, 5
  • Right ventricular infarction (these patients are preload-dependent) 3, 5
  • Marked bradycardia or tachycardia 3, 5

Blood Pressure Targets

  • Do not reduce systolic BP below 110 mmHg in normotensive patients 2, 5
  • In hypertensive patients, reduce mean arterial pressure by no more than 25% in the first hour 2, 5

Maximum Dosing

  • The commonly recommended ceiling is 200 mcg/min (120 drops/min), though this is not an absolute limit 2, 3, 5
  • Doses up to 400 mcg/min have been safely used in refractory cases 3, 5

Practical Recommendation

Given the significant variability and imprecision of gravity-driven micro-drip delivery, use a volumetric infusion pump instead of counting drops. 1, 4 If a pump is unavailable and you must use gravity drip, start at 6 drops/min (10 mcg/min with 100 mcg/mL concentration) and titrate by 3-6 drops/min every 3-5 minutes, but recognize this method carries substantial risk of dosing errors. 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nitroglycerin Infusion Guidelines for Acute Angina or Myocardial Infarction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Maximum Recommended Nitroglycerin Infusion Rate

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.